Evidence map›Paper›PMID 40119487›Full record

ArticleScandinavian journal of public health2026

Smoking and the occurrence of larynx cancer in Sweden - a population analysis.

Bengt Järvholm, Per Liv, Linnea Hedman, Maréne Landström, Kjell Torén, Alex Burdorf

Abstract read
In one paragraph

Article in Scandinavian journal of public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bengt JärvholmDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.ORCID 0000-0002-8169-8820
Per LivDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Linnea HedmanDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Maréne LandströmPathology Section, Department of Medical Biosciences, Umeå University, Umeå, Sweden.
Kjell TorénDepartment of Public Health and Community Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Alex BurdorfDepartment of Public Health, Erasmus MC, Rotterdam, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo study the importance of decreasing tobacco smoking on the occurrence of larynx cancer in men and women.

methodsThe incidence rates of larynx cancer in the Swedish population between 1970 and 2021 were retrieved from the Swedish Cancer Register for ages 50-84 years, stratified for sex, age and calendar year. Data on the population's smoking habits was retrieved from surveys and from taxation on the sale of cigarettes. The occurrence of larynx cancer was compared to smoking habits, sex and age. The time trends were compared between larynx and lung cancer.

resultsOver the years, Swedish men and women have had different smoking habits, especially older persons during the 1970s. In 1963, the prevalence of current smokers in women 50-69 years was 11%, while it was 46% in men. Around 2020, less than 10% of men and women in all age groups were current smokers. However, men had higher incidence rates of larynx cancer than women, even when their smoking habits were similar. For example, men and women 60-64 years of age in 2017-2021 had similar smoking habits during their life but the relative risk of larynx cancer in men compared to women was 3.3 (95% CI 1.7-4.8). However, pipe smoking was much more common in men.

conclusions

Indexed as

Laryngeal NeoplasmsSmokingAgedAged, 80 and overFemaleHumansIncidenceMaleMiddle AgedRegistriesSwedenAsbestosepidemiologysmokingtobacco

Identifiers

PMID40119487
PMCPMC12936125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.